NCT05607420
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05607420
Title Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma (NatHaLi-01)
Acronym NatHaLi-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cellectis S.A.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
The University of Chicago Medical Center (UCMC) RECRUITING Chicago Illinois 60637 United States Details
Harvard Medical School - Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Rutgers Cancer Institute of New Jersey (CINJ) - New Brunswick RECRUITING New Brunswick New Jersey 08901 United States Details
Sarah Cannon - St. David South Austin Medical Center RECRUITING Austin Texas 78704 United States Details
Hospices Civils de Lyon (HCL) - Centre Hospitalier Lyon-Sud RECRUITING Pierre-Bénite Auvergne Rhone Alpe 69310 France Details
Centre Hospitalier Universitaire de Montpellier (CHU Montpellier) - Hopital Saint-Eloi RECRUITING Montpellier Occitanie 34295 France Details
Centre Hospitalier Universitaire de Nantes (CHU de Nantes)-Hotel-Dieu RECRUITING Nantes 44093 France Details
Assistance Publique-Hopitaux de Paris (AP-HP) - Hopital Saint-Louis - Centre Integre en Cancerologie RECRUITING Paris Île-de-France Region 75010 France Details
Universidad de Navarra - Clinica Universidad de Navarra (CUN) - Pamplona RECRUITING Pamplona Navarre 31008 Spain Details
Hospital Universitario Virgen del Rocio (HUVR) - Instituto de Biomedicina de Sevilla (IBIS) RECRUITING Seville 41013 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field